Maternal Metabolic Health and Mother and Baby Health Outcomes (MAMBO): Protocol of a Prospective Observational Study
JMIR Research Protocols · 2025
DOI: 10.2196/72542 ↗At a glance
Studienprotokoll in JMIR Research Protocols, 2025. Written by Sarah A L Price and 4 co-authors. Institution: Department of Medicine, University of Melbourne, Melbourne, Australia. Major MEDLINE topics: Pregnancy Complications, Maternal Health, Infant Health, Metabolic Diseases. Cited 2 times so far (Crossref); 34 references. The full text is freely available in PubMed Central. Funded by: National Health and Medical Research Foundation (NHMRC) investigator grant.
Abstract (original language)
Background
Metabolic disease is increasingly impacting women of reproductive age. In pregnancy, uncontrolled metabolic disease can result in offspring with major congenital anomalies, preterm birth, and abnormal fetal growth. Pregnancy also accelerates the complications of metabolic diseases in mothers resulting in an increased risk of premature cardiovascular events. Despite the convincing evidence that preconception care can largely mitigate the risks of metabolic disease in pregnancy, there are few data about how to identify the highest-risk women so that they can be connected with appropriate preconception care services.
Objective
The aim of the study is to determine the maternal phenotype that represents the highest risk of having adverse neonatal and maternal pregnancy outcomes.
Methods
This will be a prospective cohort study of 500 women recruited in early pregnancy. The primary outcome is a composite of offspring born small for gestational age (SGA) or large for gestational age (LGA) (customized birthweight ≤10th and ≥90th centile for gestational age). Secondary outcomes are (1) composite of adverse neonatal birth outcomes (SGA, LGA, major congenital abnormalities, preterm birth [
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Medicine, University of Melbourne, Melbourne, Australia.
- Department of Obstetric Medicine, Royal Women's Hospital, Melbourne, Australia.
- Department of Diabetes and Endocrinology, The Royal Melbourne Hospital, Melbourne, Australia.
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
- Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne, Melbourne, Australia.
- Maternity Services, Royal Women's Hospital, Melbourne, Australia.
ORCID profiles: Sarah A L Price, Digsu N Koye, Alice Lewin, Alison Nankervis, Stefan C Kane
Funding
- National Health and Medical Research Foundation (NHMRC) investigator grant
Cite
APA
Price, S. A. L., Koye, D. N., Lewin, A., Nankervis, A., & Kane, S. C. (2025). Maternal Metabolic Health and Mother and Baby Health Outcomes (MAMBO): Protocol of a Prospective Observational Study. JMIR Research Protocols. https://doi.org/10.2196/72542
Vancouver
Price SAL, Koye DN, Lewin A, Nankervis A, Kane SC. Maternal Metabolic Health and Mother and Baby Health Outcomes (MAMBO): Protocol of a Prospective Observational Study. JMIR Research Protocols. 2025. doi:10.2196/72542
BibTeX
@article{Price2025,
author = {Price, Sarah A L and Koye, Digsu N and Lewin, Alice and Nankervis, Alison and Kane, Stefan C},
title = {Maternal Metabolic Health and Mother and Baby Health Outcomes (MAMBO): Protocol of a Prospective Observational Study},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/72542}
}
EUVIMED